205 related articles for article (PubMed ID: 37934757)
1. KSHV vIL-6 enhances inflammatory responses by epigenetic reprogramming.
Inagaki T; Wang KH; Kumar A; Izumiya C; Miura H; Komaki S; Davis RR; Tepper CG; Katano H; Shimoda M; Izumiya Y
PLoS Pathog; 2023 Nov; 19(11):e1011771. PubMed ID: 37934757
[TBL] [Abstract][Full Text] [Related]
2. KSHV vIL-6 Enhances Inflammatory Responses by Epigenetic Reprogramming.
Inagaki T; Wang KH; Kumar A; Izumiya C; Miura H; Komaki S; Davis RR; Tepper CG; Katano H; Shimoda M; Izumiya Y
bioRxiv; 2023 Jul; ():. PubMed ID: 37503036
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3.
Rivera-Soto R; Dissinger NJ; Damania B
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801855
[TBL] [Abstract][Full Text] [Related]
4. Virally encoded interleukin-6 facilitates KSHV replication in monocytes and induction of dysfunctional macrophages.
Shimoda M; Inagaki T; Davis RR; Merleev A; Tepper CG; Maverakis E; Izumiya Y
PLoS Pathog; 2023 Oct; 19(10):e1011703. PubMed ID: 37883374
[TBL] [Abstract][Full Text] [Related]
5. Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
Polizzotto MN; Uldrick TS; Wang V; Aleman K; Wyvill KM; Marshall V; Pittaluga S; O'Mahony D; Whitby D; Tosato G; Steinberg SM; Little RF; Yarchoan R
Blood; 2013 Dec; 122(26):4189-98. PubMed ID: 24174627
[TBL] [Abstract][Full Text] [Related]
6. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.
Uldrick TS; Wang V; O'Mahony D; Aleman K; Wyvill KM; Marshall V; Steinberg SM; Pittaluga S; Maric I; Whitby D; Tosato G; Little RF; Yarchoan R
Clin Infect Dis; 2010 Aug; 51(3):350-8. PubMed ID: 20583924
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Kaposi's sarcoma-associated herpesvirus interleukin-6 function by hypoxia-upregulated protein 1.
Giffin L; Yan F; Ben Major M; Damania B
J Virol; 2014 Aug; 88(16):9429-41. PubMed ID: 24920810
[TBL] [Abstract][Full Text] [Related]
8. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1.
Hu D; Wang V; Yang M; Abdullah S; Davis DA; Uldrick TS; Polizzotto MN; Veeranna RP; Pittaluga S; Tosato G; Yarchoan R
J Virol; 2016 Jan; 90(1):368-78. PubMed ID: 26491160
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's Sarcoma-Associated Herpesvirus Interleukin-6 Modulates Endothelial Cell Movement by Upregulating Cellular Genes Involved in Migration.
Giffin L; West JA; Damania B
mBio; 2015 Dec; 6(6):e01499-15. PubMed ID: 26646010
[TBL] [Abstract][Full Text] [Related]
10. Viral interleukin-6 encoded by an oncogenic virus promotes angiogenesis and cellular transformation by enhancing STAT3-mediated epigenetic silencing of caveolin 1.
Li W; Wang Q; Qi X; Guo Y; Lu H; Chen Y; Lu Z; Yan Q; Zhu X; Jung JU; Tosato G; Gao SJ; Lu C
Oncogene; 2020 Jun; 39(23):4603-4618. PubMed ID: 32393833
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma-associated herpesviral IL-6 and human IL-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation.
Kang JG; Majerciak V; Uldrick TS; Wang X; Kruhlak M; Yarchoan R; Zheng ZM
J Pathol; 2011 Nov; 225(3):378-89. PubMed ID: 21984125
[TBL] [Abstract][Full Text] [Related]
12. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.
Parravicini C; Corbellino M; Paulli M; Magrini U; Lazzarino M; Moore PS; Chang Y
Am J Pathol; 1997 Dec; 151(6):1517-22. PubMed ID: 9403701
[TBL] [Abstract][Full Text] [Related]
13. Runaway Kaposi Sarcoma-associated herpesvirus replication correlates with systemic IL-10 levels.
Caro-Vegas C; Sellers S; Host KM; Seltzer J; Landis J; Fischer WA; Damania B; Dittmer DP
Virology; 2020 Jan; 539():18-25. PubMed ID: 31629226
[TBL] [Abstract][Full Text] [Related]
14. KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies.
Carbone A; De Paoli P; Gloghini A; Vaccher E
Int J Cancer; 2015 Jul; 137(2):251-61. PubMed ID: 24771491
[TBL] [Abstract][Full Text] [Related]
15. Clinical Manifestations of Kaposi Sarcoma Herpesvirus Lytic Activation: Multicentric Castleman Disease (KSHV-MCD) and the KSHV Inflammatory Cytokine Syndrome.
Polizzotto MN; Uldrick TS; Hu D; Yarchoan R
Front Microbiol; 2012; 3():73. PubMed ID: 22403576
[TBL] [Abstract][Full Text] [Related]
16. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
Katano H
Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
[TBL] [Abstract][Full Text] [Related]
17. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1.
Wang V; Davis DA; Deleage C; Brands C; Choi HS; Haque M; Yarchoan R
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801863
[TBL] [Abstract][Full Text] [Related]
18. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6.
Hideshima T; Chauhan D; Teoh G; Raje N; Treon SP; Tai YT; Shima Y; Anderson KC
Clin Cancer Res; 2000 Mar; 6(3):1180-9. PubMed ID: 10741750
[TBL] [Abstract][Full Text] [Related]
19. Genetic Analyses of Contributions of Viral Interleukin-6 Interactions and Signaling to Human Herpesvirus 8 Productive Replication.
Li Q; Xiang Q; Chen D; Nicholas J
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669340
[TBL] [Abstract][Full Text] [Related]
20. Oroxylin A inhibits Kaposi's sarcoma-associated herpes virus (KSHV) vIL-6-mediated lymphatic reprogramming of vascular endothelial cells through modulating PPARγ/Prox1 axis.
Zhu X; Chen Y; Zhu W; Ji M; Xu J; Guo Y; Gao F; Gu W; Yang X; Zhang C
J Med Virol; 2019 Mar; 91(3):463-472. PubMed ID: 30318784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
